• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用粒细胞集落刺激因子动员的志愿者捐献者外周血干细胞产量的相关因素:捐献者特征和操作设置的影响

Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings.

作者信息

Wang Tso-Fu, Wen Shu-Hui, Chen Rong-Long, Lu Chi-Jui, Zheng Ya-Jun, Yang Shang-Hsien, Chu Sung-Chao, Kao Ruey-Ho, Chen Shu-Huey

机构信息

Department of Hematology and Oncology, Tzu-Chi General Hospital, and Department of Public Health, College of Medicine, Tzu-Chi University, Hualien, Taiwan.

出版信息

Biol Blood Marrow Transplant. 2008 Nov;14(11):1305-11. doi: 10.1016/j.bbmt.2008.09.002.

DOI:10.1016/j.bbmt.2008.09.002
PMID:18940686
Abstract

Peripheral blood stem cells (PBSCs) are increasingly used as the source of hematopoietic stem cells, but there are large variations in harvest outcome between individuals mobilized by granulocyte colony-stimulating factor (G-CSF). We examined the effects of donor characteristics and procedure factors on the day 1 CD34+ cell yield in 373 unrelated healthy donors. G-CSF was administered subcutaneously at a planned dose of 8.3 to 11 microg/kg daily for 5 days, followed by harvest started on day 5 of G-CSF treatment. Of the 373 donors, 159 (42.6%) had the radial artery as the inlet access for harvest. Poor day 1 cell yield was defined as <10x10(6) CD34+ cells/L of processed blood for the first apheresis; 62 donors (16.6%) did not attain this threshold. The male donors had significantly higher yields at harvest compared with the female donors. The female donors had higher CD34+ cell yields if the circulation access was through an artery than if is was through a vein. In a multiple regression analysis, donor age, sex, body mass index (BMI), preharvest white blood cell and circulating immature cell counts, access type, and flow rate correlated with day 1 yield. Female sex, older age, venous access, and a higher flow rate were significantly associated with greater risk for a day 1 poor yield of CD34+ cells (odds ratio=3.0074, 1.045, 4.3362, and 1.1131, respectively). A higher BMI may decrease the risk (odds ratio=0.8472). In donors at higher risk for poor CD34+ cell yield, strategies for increasing CD34+ cells must be considered.

摘要

外周血干细胞(PBSCs)越来越多地被用作造血干细胞的来源,但在接受粒细胞集落刺激因子(G-CSF)动员的个体之间,采集结果存在很大差异。我们研究了供体特征和操作因素对373名无关健康供体第1天CD34+细胞产量的影响。G-CSF按计划剂量8.3至11微克/千克皮下注射,每日1次,共5天,随后在G-CSF治疗第5天开始采集。在373名供体中,159名(42.6%)以桡动脉作为采集的输入通路。第1天细胞产量不佳定义为首次单采处理血液中CD34+细胞<10×10⁶个/升;62名供体(16.6%)未达到此阈值。与女性供体相比,男性供体采集时的产量显著更高。如果循环通路是通过动脉,女性供体的CD34+细胞产量高于通过静脉的情况。在多元回归分析中,供体年龄、性别、体重指数(BMI)、采集前白细胞和循环未成熟细胞计数、通路类型和流速与第1天产量相关。女性、年龄较大、静脉通路和较高流速与第1天CD34+细胞产量不佳的风险显著相关(优势比分别为3.0074、1.045、4.3362和1.1131)。较高的BMI可能会降低风险(优势比=0.8472)。对于CD34+细胞产量不佳风险较高的供体,必须考虑增加CD34+细胞的策略。

相似文献

1
Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings.使用粒细胞集落刺激因子动员的志愿者捐献者外周血干细胞产量的相关因素:捐献者特征和操作设置的影响
Biol Blood Marrow Transplant. 2008 Nov;14(11):1305-11. doi: 10.1016/j.bbmt.2008.09.002.
2
Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.健康供体中与粒细胞集落刺激因子诱导的外周血干细胞产量相关的因素。
Vox Sang. 2005 Nov;89(4):229-35. doi: 10.1111/j.1423-0410.2005.00701.x.
3
Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.400名使用粒细胞集落刺激因子(G-CSF)动员的正常供者的外周血干细胞产量:年龄、性别、供者体重及所用G-CSF类型的影响
Br J Haematol. 2006 Sep;134(5):517-25. doi: 10.1111/j.1365-2141.2006.06223.x.
4
Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.供者动员前造血祖细胞计数可预测健康供者粒细胞集落刺激因子动员后外周血造血干细胞采集物中 CD34+细胞的产量。
Transfusion. 2010 May;50(5):1088-95. doi: 10.1111/j.1537-2995.2009.02546.x. Epub 2009 Dec 29.
5
Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.粒细胞集落刺激因子动员的外周血祖细胞第二次捐献:与CD34+细胞低产量相关的危险因素
Transfusion. 2005 Jan;45(1):11-5. doi: 10.1111/j.1537-2995.2005.04107.x.
6
Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.健康志愿者中使用来格司亭动员的外周血祖细胞:一项开放标签随机分剂量递增研究。
Bone Marrow Transplant. 2000 Feb;25(4):371-6. doi: 10.1038/sj.bmt.1702168.
7
Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.在健康供体中,采用16微克/千克与10微克/千克的粒细胞集落刺激因子(G-CSF)进行干细胞动员以用于异基因移植。
Bone Marrow Transplant. 2002 May;29(9):727-30. doi: 10.1038/sj.bmt.1703509.
8
Factors affecting PBSC mobilization and collection in healthy donors.影响健康供体中PBMC动员和采集的因素。
Transfus Apher Sci. 2005 Nov;33(3):275-83. doi: 10.1016/j.transci.2005.07.007. Epub 2005 Oct 4.
9
Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.预测用于异基因移植的儿科供体外周血祖细胞采集的因素。
Haematologica. 2003 Aug;88(8):919-22.
10
Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.外周血循环未成熟细胞计数可预测健康供者在粒细胞集落刺激因子诱导的外周血造血干细胞动员中CD34+细胞的产量。
Transfusion. 2004 Apr;44(4):526-32. doi: 10.1111/j.1537-2995.2004.03078.x.

引用本文的文献

1
Graft Source Choice.移植物来源的选择。
Adv Exp Med Biol. 2025;1475:57-75. doi: 10.1007/978-3-031-84988-6_4.
2
Risk of ankylosing spondylitis in long-term follow-up of hematopoietic stem cell donors: impact of HLA-B27 status and donation type.造血干细胞供者长期随访中强直性脊柱炎的风险:HLA - B27状态和捐献类型的影响
Int J Hematol. 2025 May;121(5):684-693. doi: 10.1007/s12185-025-03926-0. Epub 2025 Feb 27.
3
Optimizing Granulocyte-Colony Stimulating Factor Dosing Scheme in Healthy Stem Cell Donors for Allogenic Transplantation: A Retrospective Cohort Study of Single Dose vs. Split Dose.
优化健康干细胞供体用于异基因移植的粒细胞集落刺激因子给药方案:单剂量与分剂量的回顾性队列研究
Cureus. 2024 Dec 29;16(12):e76553. doi: 10.7759/cureus.76553. eCollection 2024 Dec.
4
The Relationship between the Lifestyle of the Allogeneic Stem Cell Donors and the Number of Donated CD34 and CD3 Cells.异基因干细胞供者的生活方式与捐赠的CD34和CD3细胞数量之间的关系。
Int J Hematol Oncol Stem Cell Res. 2024 Jul 1;18(3):210-219. doi: 10.18502/ijhoscr.v18i3.16101.
5
CD34+ cell yield among healthy donors: Large-scale model development and validation.健康供者中 CD34+ 细胞产量:大规模模型的建立和验证。
J Clin Apher. 2024 Jun;39(3):e22135. doi: 10.1002/jca.22135.
6
Platelet-derived circulating soluble P-selectin is sufficient to induce hematopoietic stem cell mobilization.血小板衍生的循环可溶性 P 选择素足以诱导造血干细胞动员。
Stem Cell Res Ther. 2023 Oct 20;14(1):300. doi: 10.1186/s13287-023-03527-w.
7
Correlation of Body Mass Index and Proinflammatory Cytokine Levels with Hematopoietic Stem Cell Mobilization.体重指数和促炎细胞因子水平与造血干细胞动员的相关性
J Clin Med. 2022 Jul 18;11(14):4169. doi: 10.3390/jcm11144169.
8
Addition of plerixafor in poorly mobilized allogeneic stem cell donors.添加plerixafor 可改善动员不佳的异基因造血干细胞供者。
J Clin Apher. 2022 Aug;37(4):388-394. doi: 10.1002/jca.21992. Epub 2022 May 28.
9
Generation and Characterization of Human Mesenchymal Stem Cell-Derived Smooth Muscle Cells.人骨髓间充质干细胞源性平滑肌细胞的生成与鉴定。
Int J Mol Sci. 2021 Sep 25;22(19):10335. doi: 10.3390/ijms221910335.
10
Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update.普乐沙福在自体和异基因干细胞移植中用于干细胞动员的应用:最新进展
J Blood Med. 2021 Jun 2;12:403-412. doi: 10.2147/JBM.S307520. eCollection 2021.